Insulin detemir is associated with more predictable glycemic control and lower risk of hypoglycemia compared to NPH insulin in subjects with type 1 diabetes

被引：0
|
作者：
Vague, P
Selam, JL
Skeie, S
De Leeuw, I
Willem, J
Elte, F
Haahr, H
Kristensen, A
Draeger, E
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
473
引用
收藏
页码：A116 / A117
页数：2
相关论文
共 50 条
  • [1] Insulin detemir is associated with lower risk of hypoglycemia compared to NPH insulin in people with Type 1 diabetes
    Kolendorf, K
    Prasek, M
    Santeusanio, F
    Philotheou, A
    Gall, MA
    Heller, S
    [J]. DIABETOLOGIA, 2004, 47 : A329 - A329
  • [2] Insulin detemir is associated with lower risk of hypoglycemia compared to NPH insulin in people with type 1 diabetes
    Kolendorf, K
    Pavlic-Renar, I
    San-Teusanio, F
    Philotheou, A
    Gall, MA
    Heller, S
    [J]. DIABETES, 2004, 53 : A130 - A131
  • [3] Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart
    Vague, P
    Selam, JL
    Skeie, S
    De Leeuw, I
    Elte, JWF
    Haahr, H
    Kristensen, A
    Draeger, E
    [J]. DIABETES CARE, 2003, 26 (03) : 590 - 596
  • [4] Benefits of insulin detemir over NPH insulin in children and adolescents with type 1 diabetes:: Lower and more predictable fasting plasma glucose and lower risk of nocturnal hypoglycemia
    Robertson, K
    Schönle, E
    Gucev, Z
    Mordhorst, L
    Tamer, SC
    Gall, MA
    Ludvigsson, J
    [J]. DIABETES, 2004, 53 : A144 - A144
  • [5] Lower risk of hypoglycemia at each level of glycemic control when insulin detemir is added to oral agents compared to NPH insulin in patients with type 2 diabetes
    Kolendorf, K
    Kim, H
    [J]. DIABETES, 2005, 54 : A121 - A121
  • [6] Lower within-subject variability of insulin detemir compared to NPH insulin and insulin glargine in subjects with Type 1 diabetes.
    Heise, T
    Nosek, L
    Draeger, E
    Ronn, BB
    Kapitza, C
    Heinemann, L
    [J]. DIABETOLOGIA, 2003, 46 : A6 - A7
  • [7] Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes - A randomized clinical trial
    Home, P
    Bartley, P
    Russell-Jones, D
    Hanaire-Broutin, H
    Heeg, JE
    Abrams, P
    Landin-Olsson, M
    Hylleberg, B
    Lang, H
    Draeger, E
    [J]. DIABETES CARE, 2004, 27 (05) : 1081 - 1087
  • [8] Lower rate of hypoglycaemia but comparable glycaemic control with insulin detemir compared to NPH insulin in patients with type 1 diabetes
    Hermansen, K.
    Heller, S.
    Andersen, M.
    Russell-Jones, D. L.
    [J]. DIABETOLOGIA, 2009, 52 : S359 - S359
  • [9] Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes
    Robertson, K. J.
    Schoenle, E.
    Gucev, Z.
    Mordhorst, L.
    Gall, M. -A.
    Ludvigsson, J.
    [J]. DIABETIC MEDICINE, 2007, 24 (01) : 27 - 34
  • [10] Benefits of insulin detemir over NPH insulin in children and adolescents with Type 1 diabetes:: Lower and more predictable fasting plasma glucose and lower risk of nocturnal hypoglycaemia
    Robertson, KJ
    Schönle, E
    Gucev, Z
    Mordhorst, L
    Tamer, SC
    Gall, MA
    Ludvigsson, J
    [J]. DIABETOLOGIA, 2004, 47 : A32 - A32
12345